| Symbol | ABVX |
|---|---|
| Name | ABIVAX S.A. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 7 BD HAUSSMANN, PARIS, None None |
| Telephone | 01 53 83 09 63 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001956827 |
| Description | None |
New Form SCHEDULE 13G/A - Abivax S.A. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001193125-26-352351 <b>Size:</b> 19 KB
Read moreNew Form SCHEDULE 13G/A - Abivax S.A. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0002005369-26-000043 <b>Size:</b> 27 KB
Read moreAbivax renforce ses capacités commerciales avec des nominations stratégiques à des postes clés
Read moreAbivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
Read moreNew Form SCHEDULE 13D/A - Abivax S.A. <b>Filed:</b> 2026-07-06 <b>AccNo:</b> 0001104659-26-080877 <b>Size:</b> 26 KB
Read moreAbivax annonce la réalisation de son offre au public de 920 millions de dollars
Read moreNew Form 424B5 - Abivax S.A. <b>Filed:</b> 2026-07-02 <b>AccNo:</b> 0001193125-26-294491 <b>Size:</b> 1 MB
Read moreAbivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)
Read moreAbivax annonce l’exercice intégral de l’option de souscription d’ADS supplémentaires des teneurs de livre associés, portant le produit brut de l’Offre à 920 M$ (807 M€)
Read more